Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142090 · ClinicalTrials.gov registry record · NA
Use of Salt-Water Solution to Improve Symptoms in Concussion
A NA study, sponsored by Rady Children's Hospital, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00142090 is a NA study that has completed, run by Rady Children's Hospital, San Diego. The registered enrollment target is 8 participants.
The verdict
NCT00142090, a NA study, has completed, sponsored by Rady Children's Hospital, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if 3% hypertonic saline (salt-water solution) given in a vein improves the headache that may be caused by a concussion. 3% hypertonic saline may also improve some of the other symptoms that may be caused by concussion (for example: confusion, nausea, vomiting). This research is being done because there have been previous experience which suggests that 3% hypertonic saline has been beneficial in the treatment of children with more severe brain injury.
Interventions
- DRUG Placebo
- DRUG 3% Hypertonic saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00142090
The ClinicalTrials.gov registry entry for NCT00142090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rady Children's Hospital, San Diego, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00142090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00142090 about?
NCT00142090 is a clinical study titled "Use of Salt-Water Solution to Improve Symptoms in Concussion". The purpose of this study is to find out if 3% hypertonic saline (salt-water solution) given in a vein improves the headache that may be caused by a concussion. 3% hypertonic saline may also improve some of the other symptoms that may be caused by concussion (for example: confusion, nausea, vomiting...
What is the current status of trial NCT00142090?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2004-11. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00142090?
The interventions under investigation include: Placebo (DRUG), 3% Hypertonic saline (DRUG).
Who is sponsoring clinical trial NCT00142090?
This trial is sponsored by Rady Children's Hospital, San Diego, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.